Table of Content
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Product & Service
3.2. Market snippet by Technology
3.3. Market snippet by Workflow
3.4. Market Snippet by Application
3.5. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.2. Drivers
4.2.1. Increasing initiatives and funding for large-scale sequencing projects
4.2.2. Large applications of metagenomics in various fields
4.2.3. XX
4.3. Restraints
4.3.1. Budget constraints in developing countries
4.3.2. Lack of skilled professionals
4.3.3. XX
4.4. Opportunity
4.4.1. Emerging cloud computing for data management
4.5. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Clinical Trials
5.4. Pricing Analysis
5.5. Regulatory Analysis
5.6. Reimbursement Analysis
5.7. Unmet Needs
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product & Service
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service Segment
7.3. Market Attractiveness Index, By Product & Service Segment
7.3.1. Instruments*
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3.2. Reagents & Consumables
7.3.3. Analyses & Data Interpretation Solutions
7.3.4. Services
7.3.5. Others
8. By Workflow
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Workflow
8.1.2. Market Attractiveness Index, By Workflow Segment
8.2. Data Processing & Analysis *
8.2.1. Introduction
8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3. Sample Processing & Library Preparation
8.4. Sequencing
9. By Technology
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
9.1.2. Market Attractiveness Index, By Technology Segment
9.2. Shotgun Metagenomic Sequencing*
9.2.1. Introduction
9.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
9.3. 16S rRNA Sequencing
9.4. Whole Genome Sequencing & De Novo Assembly
9.5. Metatranscriptomics
10. By Application
10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
10.3. Market Attractiveness Index, By Application Segment
10.3.1. Drug Discovery*
10.3.1.1. Introduction
10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
10.3.2. Clinical Diagnostics
10.3.3. Veterinary Applications
10.3.4. Ecological and Environmental Applications
10.3.5. Industrial applications
10.3.6. Soil Microbiome Applications
10.3.7. Others
11. By Region
11.1. Introduction
11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
11.3. Market Attractiveness Index, By Region
11.4. North America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Workflow
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. The U.S.
11.4.7.2. Canada
11.4.7.3. Mexico
11.5. Europe
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Workflow
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. Germany
11.5.7.2. The U.K.
11.5.7.3. France
11.5.7.4. Italy
11.5.7.5. Spain
11.5.7.6. Rest of Europe
11.6. South America
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Workflow
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.6.7.1. Brazil
11.6.7.2. Argentina
11.6.7.3. Rest of South America
11.7. Asia Pacific
11.7.1. Introduction
11.7.2. Key Region-Specific Dynamics
11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Workflow
11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.7.7.1. China
11.7.7.2. India
11.7.7.3. Japan
11.7.7.4. Australia
11.7.7.5. Rest of Asia Pacific
11.8. The Middle East and Africa
11.8.1. Introduction
11.8.2. Key Region-Specific Dynamics
11.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
11.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Workflow
11.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
11.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Thermo Fisher Scientific Inc.*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Qiagen N.V.
13.3. BGI Group
13.4. DNAstar, Inc.
13.5. Eurofins Scientific
13.6. Illumina, Inc.
13.7. Macrogen, Inc.
13.8. Oxford Nanopore Technologies Ltd.
13.9. NuGEN Technologies, Inc. (A Wholly Owned Subsidiary of Tecan Trading AG)
13.10. F. Hoffmann-La Roche Ltd.
13.11. Perkinelmer, Inc.
13.12. Integragen SA
13.13. Microsynth AG
13.14. Novogene Co., Ltd.
13.15. Zymo Research Corporation (List Not Exhaustive)
14. DataM Intelligence
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us